A New Approach to the Classification of Idiopathic Inflammatory MyopathyLori A. Love, Frederick W. Miller, Richard L. Leff et al.|Medicine|1991Cited by 974
Aristolochic acid and the etiology of endemic (Balkan) nephropathyArthur P. Grollman, Bojan Jelaković, Shinya Shibutani et al.|Proceedings of the National Academy of Sciences|2007Cited by 598
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset diseaseDavid Isenberg, Frederick W. Miller, Elizabeth Allen et al.|Lara D. Veeken|2003Cited by 367
Controlled Trial of Plasma Exchange and Leukapheresis in Polymyositis and DermatomyositisFrederick W. Miller, Paul H. Plötz, Susan F. Leitman et al.|New England Journal of Medicine|1992Cited by 334
Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacyMarshall M. Joffe, Frederick W. Miller, Lori A. Love et al.|The American Journal of Medicine|1993Cited by 313